A detailed history of Pro Share Advisors LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 8,371 shares of ATRC stock, worth $199,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,371
Previous 7,712 8.55%
Holding current value
$199,397
Previous $275,000 7.64%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$28.21 - $37.78 $18,590 - $24,897
659 Added 8.55%
8,371 $254,000
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $54,730 - $71,751
1,659 Added 27.41%
7,712 $275,000
Q3 2023

Nov 13, 2023

SELL
$41.12 - $57.73 $246 - $346
-6 Reduced 0.1%
6,053 $265,000
Q2 2023

Aug 10, 2023

BUY
$40.44 - $49.6 $28,024 - $34,372
693 Added 12.91%
6,059 $299,000
Q1 2023

May 11, 2023

SELL
$35.87 - $47.22 $17,935 - $23,610
-500 Reduced 8.52%
5,366 $222,000
Q4 2022

Feb 02, 2023

BUY
$33.48 - $47.45 $196,393 - $278,341
5,866 New
5,866 $260,000
Q2 2022

Aug 01, 2022

SELL
$35.1 - $66.01 $115,128 - $216,512
-3,280 Reduced 39.04%
5,121 $210,000
Q1 2022

May 10, 2022

SELL
$57.43 - $71.39 $79,540 - $98,875
-1,385 Reduced 14.15%
8,401 $552,000
Q4 2021

Feb 08, 2022

BUY
$63.4 - $87.14 $256,326 - $352,307
4,043 Added 70.4%
9,786 $680,000
Q3 2021

Nov 12, 2021

SELL
$69.28 - $84.46 $405,772 - $494,682
-5,857 Reduced 50.49%
5,743 $399,000
Q2 2021

Aug 13, 2021

SELL
$64.13 - $80.18 $5,322 - $6,654
-83 Reduced 0.71%
11,600 $920,000
Q1 2021

May 14, 2021

BUY
$53.79 - $66.98 $107,364 - $133,692
1,996 Added 20.6%
11,683 $765,000
Q4 2020

Feb 09, 2021

BUY
$34.56 - $57.55 $149,472 - $248,903
4,325 Added 80.66%
9,687 $539,000
Q3 2020

Nov 13, 2020

BUY
$38.36 - $46.91 $2,378 - $2,908
62 Added 1.17%
5,362 $214,000
Q2 2020

Aug 03, 2020

BUY
$31.78 - $51.19 $168,434 - $271,307
5,300 New
5,300 $238,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.11B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.